Suki, a startup that provides AI tools to help healthcare providers with documentation, billing and other administrative work, raised $70 million in a Series D …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
At the American College of Rheumatology annual meeting, new data was presented on the long-term safety and efficacy of bimekizumab (Bimzelx), a dual interleukin (IL)-17A/F
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. Hello, and thanks for